Cargando…

Pathogenesis and treatment of multiple myeloma

Multiple myeloma (MM) is the second‐ranking malignancy in hematological tumors. The pathogenesis of MM is complex with high heterogeneity, and the development of the disease is a multistep process. Chromosomal translocations, aneuploidy, genetic mutations, and epigenetic aberrations are essential in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Peipei, Qu, Ying, Wang, Mengyao, Chu, Bingyang, Chen, Wen, Zheng, Yuhuan, Niu, Ting, Qian, Zhiyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162151/ https://www.ncbi.nlm.nih.gov/pubmed/35665368 http://dx.doi.org/10.1002/mco2.146

Ejemplares similares

Treatment attrition rates and relevant risk factors in multiple myeloma: A real-world study in China
por: Tang, Wenjiao, et al.
Publicado: (2023)

The molecular pathogenesis of multiple myeloma
por: Bolli, Niccolò, et al.
Publicado: (2020)

Pathogenesis and treatment of multiple myeloma bone disease
por: Hiasa, Masahiro, et al.
Publicado: (2021)

ALCAM regulates multiple myeloma chemoresistant side population
por: Wang, Fangfang, et al.
Publicado: (2022)

Roles of miRNA dysregulation in the pathogenesis of multiple myeloma
por: Chen, Dan, et al.
Publicado: (2021)

Involvement of Alarmins in the Pathogenesis and Progression of Multiple Myeloma
por: Murdaca, Giuseppe, et al.
Publicado: (2021)

Molecular genetic aberrations in the pathogenesis of multiple myeloma
por: Bong, Ivyna Pau Ni, et al.
Publicado: (2023)

BMI1 regulates multiple myeloma-associated macrophage’s pro-myeloma functions
por: Zhang, Danfeng, et al.
Publicado: (2021)

The Role and Function of microRNA in the Pathogenesis of Multiple Myeloma
por: Handa, Hiroshi, et al.
Publicado: (2019)

Minimal residual disease in multiple myeloma: current status
por: Ding, Hong, et al.
Publicado: (2021)

Impact of hypoxia on the pathogenesis and therapy resistance in multiple myeloma
por: Ikeda, Sho, et al.
Publicado: (2021)

The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma
por: Liu, Cheng-Der, et al.
Publicado: (2020)

Cytokine-Mediated Dysregulation of Signaling Pathways in the Pathogenesis of Multiple Myeloma
por: Akhtar, Sabah, et al.
Publicado: (2020)

Advances in the treatment of extramedullary disease in multiple myeloma
por: Li, Yating, et al.
Publicado: (2022)

Prognostic value of diametrically polarized tumor-associated macrophages in multiple myeloma
por: Chen, Xinyi, et al.
Publicado: (2017)

Pathogenesis and Treatment of Myeloma-Related Bone Disease
por: Gau, Yuh-Ching, et al.
Publicado: (2022)

Exosomes in the Pathogenesis and Treatment of Multiple Myeloma in the Context of the Bone Marrow Microenvironment
por: Chen, Tianzeng, et al.
Publicado: (2020)

Pathogenesis of bone disease in multiple myeloma: from bench to bedside
por: Terpos, Evangelos, et al.
Publicado: (2018)

Multiple myeloma, a quintessential malignant disease of aging: a geroscience perspective on pathogenesis and treatment
por: Urban, Veronika S., et al.
Publicado: (2022)

miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance
por: Tavakoli Pirzaman, Ali, et al.
Publicado: (2023)

Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor
por: Xiao, Yao, et al.
Publicado: (2018)

Recent Progress of Exosomes in Multiple Myeloma: Pathogenesis, Diagnosis, Prognosis and Therapeutic Strategies
por: Wang, Xi, et al.
Publicado: (2021)

Elotuzumab for the treatment of multiple myeloma
por: Wang, Yucai, et al.
Publicado: (2016)

Efficacy and safety of histone deacetylase inhibitors in peripheral T-cell lymphoma: a systematic review and meta-analysis on prospective clinical trials
por: Yang, Peipei, et al.
Publicado: (2023)

Pathophysiological role of calcium channels and transporters in the multiple myeloma
por: Li, Tingting, et al.
Publicado: (2021)

Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications
por: Chen, Mengping, et al.
Publicado: (2023)

Intratumor Heterogeneity of MIF Expression Correlates With Extramedullary Involvement of Multiple Myeloma
por: Xu, Juan, et al.
Publicado: (2021)

Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis
por: Abdi, Jahangir, et al.
Publicado: (2017)

Pathogenesis of Renal Failure in Multiple Myeloma: Any Role of Contrast Media?
por: Mussap, Michele, et al.
Publicado: (2014)

Association of Chromosomal Translocation and MiRNA Expression with The Pathogenesis of Multiple Myeloma
por: Saki, Najmaldin, et al.
Publicado: (2014)

The role of lymphoid tissue SPARC in the pathogenesis and response to treatment of multiple myeloma
por: Aly, Nesreen Amer Ramadan, et al.
Publicado: (2022)

Oxygen-generating Hybrid Polymeric Nanoparticles with Encapsulated Doxorubicin and Chlorin e6 for Trimodal Imaging-Guided Combined Chemo-Photodynamic Therapy
por: Hu, DanRong, et al.
Publicado: (2018)

Myeloma Bone Disease: Update on Pathogenesis and Novel Treatment Strategies
por: Vallet, Sonia, et al.
Publicado: (2018)

Assessment tools for patient-reported outcomes in multiple myeloma
por: Wang, Ting, et al.
Publicado: (2023)

PIM Kinases in Multiple Myeloma
por: Wu, Jian, et al.
Publicado: (2021)

Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets
por: Burroughs Garcìa, Jessica, et al.
Publicado: (2021)

Cell of Origin and Genetic Alterations in the Pathogenesis of Multiple Myeloma
por: Barwick, Benjamin G., et al.
Publicado: (2019)

Biodegradable CSMA/PECA/Graphene Porous Hybrid Scaffold for Cartilage Tissue Engineering
por: Liao, JinFeng, et al.
Publicado: (2015)

Mesoporous Magnetic Gold “Nanoclusters” as Theranostic Carrier for Chemo-Photothermal Co-therapy of Breast Cancer
por: Peng, JinRong, et al.
Publicado: (2014)

Pomalidomide for the Treatment of Multiple Myeloma
por: Clark, Stephen M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_67lrlklsptm6c6j92uumehshj0